This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ICAD icad (ICAD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About icad Stock (NASDAQ:ICAD) Get icad alerts:Sign Up Key Stats Today's Range$3.87▼$3.8750-Day Range$3.65▼$3.9552-Week Range$3.17▼$4.02VolumeN/AAverage Volume373,781 shsMarket Capitalization$106.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Read More Receive ICAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for icad and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ICAD Stock News HeadlinesICADE (ICAD) Stock Forecast & Price TargetApril 17, 2026 | investing.comAI Mammogram Technology Offers 23% Greater Cancer Detection, Fewer False PositivesFebruary 25, 2026 | tmcnet.comBuy this stock tomorrowMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.June 18 at 1:00 AM | Chaikin Analytics (Ad)Orange County radiologists use AI to detect breast cancer earlier, saving livesJanuary 1, 2026 | msn.comTAQA Energy Services, Sdeira Group launch building retrofit project at Aryam ICAD Residential CityNovember 14, 2025 | msn.comRadNet raises 2025 revenue guidance as advanced imaging volumes and digital health drive growthNovember 10, 2025 | msn.comCSG to set up intelligent energy-saving glass plant in Abu DhabiOctober 8, 2025 | msn.comQ Mobility to develop truck and on-street parking solutions in KEZADAugust 9, 2025 | msn.comSee More Headlines ICAD Stock Analysis - Frequently Asked Questions How were icad's earnings last quarter? icad inc. (NASDAQ:ICAD) released its quarterly earnings results on Tuesday, May, 13th. The technology company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.04. The technology company earned $4.87 million during the quarter, compared to the consensus estimate of $4.54 million. icad had a negative trailing twelve-month return on equity of 15.03% and a negative net margin of 26.63%. What other stocks do shareholders of icad own? Based on aggregate information from My MarketBeat watchlists, some other companies that icad investors own include Enovix (ENVX), Globant (GLOB), Rambus (RMBS), Luminar Technologies (LAZR), Toast (TOST), Compass Pathways (CMPS) and Ginkgo Bioworks (DNA). Company Calendar Last Earnings5/13/2025Today6/18/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry COMP - SOFTWARE Sub-IndustryMedical Equipment Current SymbolNASDAQ:ICAD CIK749660 Webwww.icadmed.com Phone(603) 882-5200Fax603-880-3843Employees140Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.62 million Net Margins-26.63% Pretax Margin-26.28% Return on Equity-15.03% Return on Assets-11.77% Debt Debt-to-Equity RatioN/A Current Ratio3.66 Quick Ratio3.57 Sales & Book Value Annual Sales$19.61 million Price / Sales5.42 Cash FlowN/A Price / Cash FlowN/A Book Value$1.08 per share Price / Book3.58Miscellaneous Outstanding Shares27,470,000Free Float24,644,000Market Cap$106.31 million OptionableOptionable Beta1.37 Social Links 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NASDAQ:ICAD) was last updated on 6/18/2026 by MarketBeat.com Staff. From Our PartnersThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredDo NOT buy or sell SPCX before reading thisSpaceX may be the biggest IPO in history, but according to Joel Litman - who called AMD before it rose as much...Altimetry | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredHopeless About Retirement? Hopeless and Helpless Aren’t the Same ThingYour retirement date didn't move once - it moved slowly, then repeatedly, until the shift felt normal. That's ...Golden Portfolio | SponsoredBuy this stock tomorrowMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredTrump’s New Dollar revealedThe last time something like this happened was 1974 - a secret deal that quietly determined the financial fate...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding icad inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share icad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
